GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANW) » Definitions » Other Current Receivables

Immuron (FRA:ANW) Other Current Receivables : €0.14 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Immuron Other Current Receivables?

Immuron's Other Current Receivables for the quarter that ended in Dec. 2023 was €0.14 Mil.

Immuron's quarterly Other Current Receivables increased from Dec. 2022 (€0.09 Mil) to Jun. 2023 (€0.25 Mil) but then stayed the same from Jun. 2023 (€0.25 Mil) to Dec. 2023 (€0.14 Mil).

Immuron's annual Other Current Receivables increased from Jun. 2021 (€0.00 Mil) to Jun. 2022 (€0.30 Mil) but then declined from Jun. 2022 (€0.30 Mil) to Jun. 2023 (€0.25 Mil).


Immuron Other Current Receivables Historical Data

The historical data trend for Immuron's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Other Current Receivables Chart

Immuron Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only 0.41 0.19 - 0.30 0.25

Immuron Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.30 0.09 0.25 0.14

Immuron Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Immuron Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Immuron's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Immuron (FRA:ANW) Business Description

Industry
Traded in Other Exchanges
Address
Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANW) Headlines

No Headlines